Stem cell transplantation is not currently available for the treatment of multiple system atrophy and its effectiveness is unclear. There is no effective treatment for multiple system atrophy, and targeted treatment is the mainstay.
Stem cell transplantation usually refers to hematopoietic stem cell transplantation, which is a therapeutic method of extracting an effective number of stem cells from a hematopoietic stem cell donor and transplanting them directly into the patient’s body after a number of special treatments to help improve the patient’s hematopoietic and immune functions.
Stem cell transplantation is commonly used in the treatment of leukemia, aplastic anemia, lymphoma or myeloma, but there are no clear indications that it can be used in the treatment of multiple system atrophy.
Multiple system atrophy is a neurodegenerative disease in which multiple systems in the body show signs of atrophy, which can severely affect normal activities or basic functions.
There is no effective cure for MSA, and depending on the symptoms of atrophy, physical therapy, rehabilitation or surgery may be required to ensure basic metabolic function, bowel movement or exercise. Stem cell transplantation is not a definitive treatment for multiple systemic atrophy.
It is recommended to choose the appropriate treatment to relieve the symptoms of multiple system atrophy under the guidance of a doctor.